INS and type 1 diabetes mellitus: We found that three consecutive doses of 50 or 75 mg/kg STZ administered to high fat-fed mice induced a phenotype that was more akin to type 1 diabetes, where pancreatic insulin content was markedly diminished and thus glucose-mediated insulin secretion was almost absent.